Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial - Wikidata - awgldk - TriplyDB

Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial

Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial

http://www.wikidata.org/entity/Q28972526

about

A review of malaria vaccine clinical projects based on the WHO rainbow table Vaccines: from empirical development to rational design Male circumcision for prevention of homosexual acquisition of HIV in men The role of the foreskin in male circumcision: an evidence-based review Vaccine-induced HIV seropositivity/reactivity in noninfected HIV vaccine recipients Immunoregulatory functions of immune complexes in vaccine and therapy HIV-1 prophylactic vaccines: state of the art Recent Advances in Lentiviral Vaccines for HIV-1 Infection Methods and clinical development of adenovirus-vectored vaccines against mucosal pathogens Which New Health Technologies Do We Need to Achieve an End to HIV/AIDS?Recent update in HIV vaccine development Role of HLA Adaptation in HIV Evolution Oncolytic Adenovirus: Strategies and Insights for Vector Design and Immuno-Oncolytic Applications Animal and human mucosal tissue models to study HIV biomedical interventions: can we predict success?New approaches to understanding the immune response to vaccination and infection Cytokine production and dysregulation in HIV pathogenesis: lessons for development of therapeutics and vaccines The rise of multiple imputation: a review of the reporting and implementation of the method in medical research Tissue-resident memory T cells A New Scientific Paradigm may be Needed to Finally Develop an HIV Vaccine Sieve analysis in HIV-1 vaccine efficacy trials Nonhuman primate models for HIV/AIDS vaccine development Poxvirus vectors as HIV/AIDS vaccines in humans HIV-1 neutralizing antibodies: understanding nature's pathways Adenovirus vectors for gene therapy, vaccination and cancer gene therapy Induction of intestinal immunity by mucosal vaccines as a means of controlling HIV infection Vaccine applications of flow cytometry Vaccines for the 21st century The future of HIV vaccine research and the role of the Global HIV Vaccine Enterprise Profiling immunity to HIV vaccines with systems biology Novel recombinant alphaviral and adenoviral vectors for cancer immunotherapy Synthetic DNA vaccine strategies against persistent viral infections A global approach to HIV-1 vaccine development Live attenuated Rev-independent Nef¯SIV enhances acquisition of heterologous SIVsmE660 in acutely vaccinated rhesus macaques Use of an in vivo FTA assay to assess the magnitude, functional avidity and epitope variant cross-reactivity of T cell responses following HIV-1 recombinant poxvirus vaccination Biologically-directed modeling reflects cytolytic clearance of SIV-infected cells in vivo in macaques Immunogenicity of seven new recombinant yellow fever viruses 17D expressing fragments of SIVmac239 Gag, Nef, and Vif in Indian rhesus macaques Vaccination against heterologous R5 clade C SHIV: prevention of infection and correlates of protection A new adenovirus based vaccine vector expressing an Eimeria tenella derived TLR agonist improves cellular immune responses to an antigenic target Wanted, dead or alive: New viral vaccines Recombinant Yellow Fever Vaccine Virus 17D Expressing Simian Immunodeficiency Virus SIVmac239 Gag Induces SIV-Specific CD8+ T-Cell Responses in Rhesus Macaques

P2860

Q21034112-36DEECF9-7A13-4605-86DF-EF41B387E64A Q21089599-64E93756-B40C-4F39-96E5-47AFD4A95887 Q24236267-67663403-7CE6-46D2-91A5-94890DD9C87E Q24595905-042AB163-5608-4413-81E1-B8D2F3EFBD59 Q24602593-5A5BDC23-735F-40B2-B70A-1D6C970078F3 Q26738396-48ABB60E-F630-43F0-ADFA-EC39A06F6DA6 Q26740042-91C95493-97C2-4C36-BFDA-288DA5B8CFE9 Q26742169-A3614C29-AF2D-47D4-8A7E-14C09E09CF58 Q26750912-6A399B0D-9B36-40A2-818E-ADC70CDE224E Q26765043-3AA90920-A725-445C-9A16-C2B6121CCF0B Q26766628-63CD10E2-3814-4C20-8A38-5644DF5BB030 Q26772713-6ED0BE10-96F6-45FC-A2DE-5ED220E63B1C Q26776553-5B802CAF-B3FF-4664-B8A0-59156D97B36F Q26777022-BA440722-A006-431A-BE5C-38646C975148 Q26800283-64D617CE-9926-4552-BF3F-FEC36562C842 Q26827712-96A6307D-B22F-4C00-A3F4-DF80F42DB765 Q26828889-D1794716-993E-4349-83E6-A06454E40C4A Q26829804-A0011233-F636-45E6-BC54-15BBDFFC364E Q26830360-75ECBD81-D5C4-4B28-B3AE-3B579BC0189E Q26851376-5672DDB2-1721-4700-A0E3-4A6F70D7AE60 Q26861148-4104FFCE-1B48-479B-A957-34FC6CE4EF4F Q26995078-DB1B2BA9-B489-4839-B68F-E36C3764821C Q27000480-8960B446-22D2-4405-A9B1-D86A81BF33FE Q27001601-97068FBF-3324-4AF5-936B-4F836A80A490 Q27001897-A93019CF-FCEF-469D-BDB1-747338F4F932 Q27004341-4DCD78EA-FB93-492B-856E-88FBBF4AF9D8 Q27007529-5491FF4A-FB2F-4F55-BE4F-2BFEB1822F9E Q27010375-3F888163-78C9-4487-B1F5-6BBC31FEE5FF Q27010629-E899572A-F948-4735-B49E-0773C87E5B2C Q27013586-CAA11B84-904E-4329-AD73-2D44AE9B478B Q27016078-8D952AC8-7675-44AA-B002-43BCABB27BE5 Q27024614-BA16DA3E-AEF0-46B5-BC13-2D85BA7F7853 Q27305234-99D2E05C-FF20-478B-8356-31BEDBDCA155 Q27314609-C42863D5-EE79-4CC8-9DCD-34762487AE75 Q27319762-EA04A33A-562E-4277-A667-3FBA33F5E571 Q27319783-DF975EB4-719E-4950-9719-50CC37BC84AE Q27332360-E941A5A2-06CA-477E-8447-C8CF86990991 Q27333475-4ABEA056-2092-45E6-ACCB-A4A79B222F90 Q27489979-1F266004-23FC-4C09-8F49-A15E88AA97E7 Q27491052-84941D56-D8EB-44E0-9B4C-89A22BE620A0

P2860

Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial

http://www.wikidata.org/entity/Q28972526

description

2008 nî lūn-bûn

@nan

2008 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2008 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

name

Efficacy assessment of a cell- ...... trolled, test-of-concept trial

@ast

Efficacy assessment of a cell- ...... trolled, test-of-concept trial

@en

type

label

Efficacy assessment of a cell- ...... trolled, test-of-concept trial

@ast

Efficacy assessment of a cell- ...... trolled, test-of-concept trial

@en

prefLabel

Efficacy assessment of a cell- ...... trolled, test-of-concept trial

@ast

Efficacy assessment of a cell- ...... trolled, test-of-concept trial

@en

P1433

Q28972526-FCA849F5-FF10-4203-860D-DB0B4AF43942

P1476

Q28972526-7BF2AD16-FD87-4531-9322-B7B046DBC71C

P2093

Q28972526-039C6F39-32D0-410F-95BA-FE48F05A3C83

Q28972526-0C91A121-9EFE-4309-9E72-C3FD610A33DD

Q28972526-37566998-7A5C-4994-911C-AF4F3F28A536

Q28972526-45D11255-E539-4952-942D-6CEABC333B45

Q28972526-681A4A7D-6023-441F-BD14-A90092E82BCE

Q28972526-6C2F9936-8615-4A6F-B9AF-D70C0A4332AD

Q28972526-72F0591B-08AC-4AE9-85EF-D7BF9E8579B8

Q28972526-90FD8938-AE7C-4840-9844-93AE7D6E8741

Q28972526-945BC2DF-5E7B-48B6-B65D-F818ABE94220

Q28972526-C1C83E6B-81BA-4F23-994D-CB9A343600A8

P2860

Q28972526-09B9A332-0611-4953-88B4-2F6B1160EE09

Q28972526-1375D974-38D3-4E9E-9A0B-643C062BAA5E

Q28972526-195061C3-C5F9-4E74-96EE-827AEBA788DF

Q28972526-1B5CA826-48CA-4250-85D1-EE04F915FC26

Q28972526-1BC0435F-194A-4D9F-815F-4112BD153D87

Q28972526-29B6CFEA-A631-42EB-B12A-B62C2A161C3A

Q28972526-2B680198-2C99-4E3A-8213-98E52C80036F

Q28972526-2F8A9AB5-A62C-4D5E-A31B-290D27D9B270

Q28972526-33764357-F1CD-43A2-B70D-1A67F0F3C260

Q28972526-41466D38-FA0A-48D3-BB04-340C6C7A40E3

P304

Q28972526-E3F8CB4F-D9D5-4DA3-AF40-4FDDF5E1551D

P31

Q28972526-80FA855B-D331-4099-B1A9-632A269B3939

P3181

Q28972526-CFD99169-80BA-447E-8766-56E76033E371

P356

Q28972526-2B94F3E4-6E68-4BEC-B560-28E4E276E93F

P407

Q28972526-4131D4A0-B452-4A7B-B09E-A3587F81D9F4

P433

Q28972526-41326510-F6F6-407D-80F5-1A102DADD1A4

P478

Q28972526-854BF192-ECF5-404E-BC77-900C8972D746

P50

Q28972526-AA81B938-5361-4162-A639-D2D7E6A8F72D

Q28972526-B2B1FFF4-BCBA-4287-863B-9D2B042D2758

P5008

Q28972526-A4430C2F-9286-401E-A3A7-00A5AFF68A07

P577

Q28972526-5C5640BB-7702-43A5-B21C-7A206283B7D9

P698

Q28972526-5993AE41-CBFF-4F24-954C-05C09DE01F51

P921

Q28972526-7D9064FD-5F7F-4E41-9859-42AF7FDCEF7D

P932

Q28972526-5025DA59-4CD2-4307-BDF9-2E93F5AA0784

P3181

P356

S0140-6736(08)61591-3

P1433

P1476

Efficacy assessment of a cell- ...... trolled, test-of-concept trial

@en

P2093

Ann Duerr

http://www.w3.org/2001/XMLSchema#string

Carlos Del Rio

http://www.w3.org/2001/XMLSchema#string

Danilo R Casimiro

http://www.w3.org/2001/XMLSchema#string

David Li

http://www.w3.org/2001/XMLSchema#string

Devan V Mehrotra

http://www.w3.org/2001/XMLSchema#string

Javier R Lama

http://www.w3.org/2001/XMLSchema#string

Jeffrey A Chodakewitz

http://www.w3.org/2001/XMLSchema#string

Keith M Gottesdiener

http://www.w3.org/2001/XMLSchema#string

Lawrence Corey

http://www.w3.org/2001/XMLSchema#string

M Juliana McElrath

http://www.w3.org/2001/XMLSchema#string

P2860

Vigorous HIV-1-specific CD4+ T cell responses associated with control of viremia

Strong cytotoxic T cell and weak neutralizing antibody responses in a subset of persons with stable nonprogressing HIV type 1 infection

Statistical methods in cancer research. Volume II--The design and analysis of cohort studies

Control of viremia in simian immunodeficiency virus infection by CD8+ lymphocytes

Sexual risk, nitrite inhalant use, and lack of circumcision associated with HIV seroconversion in men who have sex with men in the United States.

Are US populations appropriate for trials of human immunodeficiency virus vaccine? The HIVNET Vaccine Preparedness Study.

Analysis of antiretroviral immunotherapy trials with potentially non-normal and incomplete longitudinal data.

HLA Alleles Associated with Delayed Progression to AIDS Contribute Strongly to the Initial CD8(+) T Cell Response against HIV-1.

Vectored Gag and Env but not Tat show efficacy against simian-human immunodeficiency virus 89.6P challenge in Mamu-A*01-negative rhesus monkeys.

Genetic and immunologic heterogeneity among persons who control HIV infection in the absence of therapy.

P304

1881-1893

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

624616

http://www.w3.org/2001/XMLSchema#string

P356

10.1016/S0140-6736(08)61591-3

http://www.w3.org/2001/XMLSchema#string

P407

P433

9653

http://www.w3.org/2001/XMLSchema#string

P478

372

http://www.w3.org/2001/XMLSchema#string

P50

Daniel W Fitzgerald

P5008

P577

2008-11-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19012954

http://www.w3.org/2001/XMLSchema#string

P921

P932

2721012

http://www.w3.org/2001/XMLSchema#string